4896 — K Pharma Cashflow Statement
0.000.00%
- ¥10bn
- ¥7bn
- ¥1bn
- 51
- 11
- 66
- 35
Annual cashflow statement for K Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Yuho |
Standards: | JAS | JAS | JAS |
Status: | Final | Final | Final |
Net Income/Starting Line | -229 | -391 | 301 |
Depreciation | |||
Non-Cash Items | 9.63 | 36.7 | 64.9 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 16.4 | -9.67 | 88.4 |
Change in Inventories | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -196 | -363 | 454 |
Capital Expenditures | — | -30 | -9.8 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | -0.25 | -2.78 | -1.3 |
Other Investing Cash Flow | |||
Cash from Investing Activities | -0.25 | -32.7 | -11.1 |
Financing Cash Flow Items | 0 | -0.09 | -10.1 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 368 | 1,544 | 1,486 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 172 | 1,148 | 1,930 |